Showing results (51-60 of 162) with videos related to

Sort By:
Pageof 17
Blood|August 24, 2012
Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2Diederik van Bodegom, Jun Zhong, Nadja Kopp, et al.
Nature|July 24, 2020
Signalling input from divergent pathways subverts B cell transformationLai N Chan, Mark A Murakami, Mark E Robinson, et al.
Blood|August 21, 2012
BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemiaChristopher J Ott, Nadja Kopp, Liat Bird, et al.
Plos One|November 13, 2012
Next-generation cDNA screening for oncogene and resistance phenotypesNobuaki Shindoh, Akinori Yoda, Yuka Yoda, et al.
EMBO Molecular Medicine|March 8, 2017
Deletion of ribosomal protein genes is a common vulnerability in human cancer, especially in concert with TP53 mutationsRam Ajore, David Raiser, Marie McConkey, et al.
Oncotarget|June 11, 2016
Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclonesThomas Melchardt, Clemens Hufnagl, David M Weinstock, et al.
Disaster Medicine and Public Health Preparedness|March 16, 2011
Medical response to a nuclear detonation: creating a playbook for state and local planners and respondersPaula Murrain-Hill, C Norman Coleman, John L Hick, et al.
Haematologica|April 2, 2026
Azacitidine-induced remission enables allogeneic transplantation in TET2/BCOR-mutant relapsed extranodal natural killer/T-cell lymphoma: a case reportCarmen de Ramon Ortiz, Hana Abouzeid, Chiara De Bernardi, et al.
Blood Advances|March 19, 2026
Live-cell Pick-Seq (LiP-Seq): Interrogating ultra-rare mantle cell lymphoma persistent cells after CART19 therapyRan Xu, Gongwei Wu, Siobhan Rice, et al.
Blood|January 22, 2020
Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusionsNoriaki Yoshida, Kay Shigemori, Nicholas Donaldson, et al.
Pageof 17